The co-delivery of multiple drugs using one
drug carrier is a viable strategy to optimize
drug dosage and reduce the side effects in
chemotherapy. Herein, a hydrophilic animal
protein (
silk fibroin) and a hydrophobic
plant protein (
zein) were selected for preparing a composite
drug carrier. Adapting our previously developed method for the preparation of regenerated
silk fibroin (RSF)
nanospheres, we prepared RSF/
zein nanospheres that displayed an interesting structure including a single central hole. The particle size of the RSF/
zein nanospheres was regulated from 150 to 460 nm by varying the preparation conditions, implying that such a
drug carrier is suitable for both
intravenous administration and lymphatic
chemotherapy. Two anti-
cancer drugs with different target sites,
paclitaxel (PTX) and
curcumin (CUR), were selected for the preparation of dual-
drug-loaded CUR/PTX@RSF/
zein nanospheres. Both drugs achieved a high loading capacity in the RSF/
zein nanospheres, i.e., 8.2% for PTX and 12.1% for CUR. Subsequently, the encapsulated PTX and CUR were released from the RSF/
zein nanospheres in a sustained manner for at least 7 days. Importantly, these dual-
drug-loaded RSF/
zein nanospheres exhibited a considerable synergistic
therapeutic effect, showing more efficient suppression of in vitro
cancer cell growth than free PTX or CUR, a combination of free PTX and CUR, or single-
drug-loaded
nanospheres. Therefore, the CUR/PTX@RSF/
zein nanospheres developed in this study hold great potential for
combination chemotherapy in future clinical applications.